ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,744Medicare Part D Prescriptions Filled, Including Refills

Rank: 602 out of 6645

$919K Total Retail Price of All Prescriptions

Rank: 383 out of 6645

258 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 258 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,290 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 462 443 1 2
CRESTOR 353 323 2 34
SIMVASTATIN 343 314 3 1
METFORMIN HCL 283 248 4 7
TAMSULOSIN HCL 234 233 5 22
ALENDRONATE SODIUM 231 215 6 14
MICARDIS 222 201 7 232
LOSARTAN POTASSIUM 219 207 8 12
ATELVIA 219 185 8 91
ZOLPIDEM TARTRATE 218 214 10 17
ATORVASTATIN CALCIUM 213 163 11 10
LEVOTHYROXINE SODIUM 175 159 12 4
TRIAMCINOLONE ACETONIDE 168 143 13 55
NIFEDIPINE ER 164 149 14 82
ACTOS 162 145 15 71
AZITHROMYCIN 156 138 16 44
OMEPRAZOLE 151 147 17 6
NEXIUM 148 145 18 40
CLOPIDOGREL 147 137 19 36
METOPROLOL SUCCINATE 132 125 20 24
LOVAZA 131 118 21 68
PLAVIX 130 125 22 49
AMOXICILLIN 128 106 23 107
DOXAZOSIN MESYLATE 119 119 24 81
VYTORIN 116 109 25 170
FAMOTIDINE 109 81 26 33
PATANOL 108 96 27 131
CLONIDINE HCL 103 101 28 56
ISOSORBIDE MONONITRATE ER 102 101 29 66
LEVOFLOXACIN 100 93 30 83
ATENOLOL 99 81 31 8
IBUPROFEN 99 90 31 42
DIOVAN 98 92 33 19
MICARDIS HCT 96 89 34 299
ALBUTEROL SULFATE 94 49 35 112
CLOTRIMAZOLE-BETAMETHASONE 92 58 36 177
LIDODERM 91 78 37 53
LOSARTAN-HYDROCHLOROTHIAZIDE 87 80 38 62
GABAPENTIN 87 63 38 18
AVODART 85 73 40 99
FINASTERIDE 85 78 40 73
DIOVAN HCT 83 74 42 64
DONEPEZIL HCL 82 77 43 27
PROAIR HFA 81 61 44 32
SURE COMFORT ALCOHOL 78 63 45 250
MEGESTROL ACETATE 78 75 R 45 104
CARVEDILOL 77 75 47 25
JANUVIA 74 74 48 38
LIPITOR 72 57 49 69
CREON 71 51 50 114
FUROSEMIDE 70 65 51 11
IPRATROPIUM BROMIDE 68 52 52 156
SINGULAIR 68 58 52 76
WARFARIN SODIUM 67 40 54 16
TRAMADOL HCL 62 62 55 30
CARBIDOPA-LEVODOPA 62 56 55 116
LANTUS 54 36 57 50
VIREAD 54 54 57 259
CIPROFLOXACIN HCL 53 48 59 67
NASONEX 53 52 59 126
QUETIAPINE FUMARATE 53 51 59 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.